Maximum quantity allowed is 999
CAS RN: 192927-63-2 | Product Number: M2479
Moxifloxacin Hydrochloride Monohydrate

Purity: >98.0%(T)(HPLC)
- 1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-[(4aS,7aS)-octahydro-1H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic Acid Hydrochloride Monohydrate
Size | Unit Price | Hyderabad | Japan* | Quantity |
---|---|---|---|---|
100MG |
₹2,800.00
|
2 | 5 |
|
1G |
₹9,900.00
|
Contact Us | 9 |
|
*Upon orders receipt, Hyderabad stocks will be dispatched on the same day.
*Items available in Japan warehouse will be dispatched in 10-12 working days.
*INR price is exclusive of domestic taxes applicable.
*TCI frequently reviews storage conditions to optimize them. Please note that the latest information on the storage temperature for the products is described on our website.
Product Number | M2479 |
Purity / Analysis Method | >98.0%(T)(HPLC) |
Molecular Formula / Molecular Weight | C__2__1H__2__4FN__3O__4·HCl·H__2O = 455.92 |
Physical State (20 deg.C) | Solid |
Storage Temperature | Room Temperature (Recommended in a cool and dark place, <15°C) |
CAS RN | 192927-63-2 |
Related CAS RN | 186826-86-8&151096-09-2 |
Reaxys Registry Number | 8377447 |
PubChem Substance ID | 354334556 |
Merck Index (14) | 6291 |
MDL Number | MFCD00949117 |
Appearance | White to Orange to Green powder to crystaline |
Purity(HPLC) | min. 98.0 area% |
Purity(Neutralization titration) | min. 98.0 % |
Specific rotation [a]20/D | -124 to -137 deg(C=0.5, water) |
Water | 3.0 to 5.0 % |
Melting Point | 240 °C(dec.) |
Maximum Absorption Wavelength | 338 nm (H__2O) |
Pictogram |
![]() |
Signal Word | Warning |
Hazard Statements | H341 : Suspected of causing genetic defects. |
Precautionary Statements | P501 : Dispose of contents/ container to an approved waste disposal plant. P202 : Do not handle until all safety precautions have been read and understood. P201 : Obtain special instructions before use. P280 : Wear protective gloves/ protective clothing/ eye protection/ face protection. P308 + P313 : IF exposed or concerned: Get medical advice/ attention. P405 : Store locked up. |
RTECS# | VB1983750 |
References
- 1)In vitro Activity of BAY 12-8039, a New 8-Methoxyquinolone
- 2)The effect of moxifloxacin on its target topoisomerases from Escherichia coli and Staphylococcus aureus
- 3)In vitro and in vivo activities of moxifloxacin and clinafloxacin against Mycobacterium tuberculosis
- 4)Moxifloxacin: A review of its use in the management of bacterial infections
- 5)Simultaneous determination of levofloxacin, gatifloxacin and moxifloxacin in serum by liquid chromatography with column switching
- 6)Optimization of separation and determination of moxifloxacin and its related substances by RP-HPLC
- 7)Solubility of Antibiotics in Different Solvents. 1. Hydrochloride Forms of Tetracycline, Moxifloxacin, and Ciprofloxacin
Articles/Brochures
Safety Data Sheet (SDS)
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Sample C of A
A sample C of A for this product is not available at this time.
Analytical Charts
The requested analytical chart is not available. Sorry for the inconvenience.